Segment & Geographic Data
Quant-Grade Normalized Data
API & CSV Delivery
Isoplexis's Business Segments
Isoplexis's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Reportable Segments
-
Largest Segment
-
Total Revenue
-
Regions Reported
3
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/ISO/segments
https://api.csimarket.com/api/v1/companies/ISO/geographic
https://api.csimarket.com/api/v1/companies/ISO/exposure
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Connect Your AI Assistant
Annual Results
Revenue Share by Region -
- Americas75.5%
- Europe7.7%
- Asia Pacific2.8%
Revenue by Geographic Region -
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Americas | $ 12 | 75.5% |
| Europe | $ 1 | 7.7% |
| Asia Pacific | $ 0 | 2.8% |
Revenue by Product & Service Category -
- Product83.8%
- Product, Instruments49.8%
- Product, Consumables34%
- Service17.6%
- Service, Other10.1%
- Service, Extended Service Warranty7.5%
Revenue by Product & Service Category -
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 14 | 83.8% |
| Product, Instruments | $ 8 | 49.8% |
| Product, Consumables | $ 6 | 34% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
3 more categories available
Sign in to unlock the full Isoplexis dataset.
Description of Isoplexis
Isoplexis Corporation is a biotechnology company that specializes in developing innovative solutions for single-cell biology research, especially in the field of immune system profiling. The company was founded in 2014 by a team of experts in single-cell genomics, genotyping, and bioinformatics. It has since become a leader in the field, offering cutting-edge technology and products to enable researchers to better understand cellular heterogeneity and immune response.
The core technology developed by Isoplexis Corporation is called the Single-Cell Intracellular Proteome Profiling (SCIPPR) platform. This platform allows for the simultaneous measurement of multiple proteins at the single-cell level, providing highly detailed and comprehensive information about the signaling states and functional heterogeneity of individual cells. SCIPPR combines high-throughput single-cell proteomics with high-resolution flow cytometry, allowing researchers to analyze hundreds to thousands of cells in a short period of time.
The SCIPPR platform consists of several components, including innovative reagents, microfluidic cartridges, and advanced bioinformatics analysis. The reagents are designed to ensure high sensitivity and specificity for protein detection, while the microfluidic cartridges enable the isolation and profiling of individual cells in a controlled and reproducible manner. The bioinformatics analysis software provides powerful tools for data visualization, statistical analysis, and interpretation of the complex single-cell data generated.
Isoplexis Corporation's technology has a wide range of applications in biomedical research, including cancer immunotherapy, infectious diseases, autoimmune disorders, and drug discovery. By profiling the immune system at the single-cell level, researchers can gain insights into the heterogeneity and dynamic changes of immune cell populations, which can lead to the development of more effective therapies and personalized medicine approaches.
In addition to the SCIPPR platform, Isoplexis Corporation offers other products and services to support single-cell biology research. This includes CellPlex, a multiplexed imaging system that allows for the visualization and quantification of multiple biomarkers in intact tissues or cell cultures. They also provide custom assay development services, where they work closely with researchers to design and optimize assays for their specific needs.
Isoplexis Corporation has established collaborations with leading academic institutions, pharmaceutical companies, and research organizations around the world. These collaborations have resulted in numerous scientific publications and presentations, showcasing the impact and potential of the company's technology. The company is committed to advancing the field of single-cell biology and driving innovations that will ultimately improve human health.
Overall, Isoplexis Corporation is a pioneering biotechnology company that has revolutionized the field of single-cell biology with its SCIPPR platform. Their technology and products enable researchers to gain a deeper understanding of cellular heterogeneity and immune response, leading to the development of more targeted and personalized therapies. With a strong focus on innovation and collaboration, Isoplexis Corporation continues to push the boundaries of single-cell biology research.
The core technology developed by Isoplexis Corporation is called the Single-Cell Intracellular Proteome Profiling (SCIPPR) platform. This platform allows for the simultaneous measurement of multiple proteins at the single-cell level, providing highly detailed and comprehensive information about the signaling states and functional heterogeneity of individual cells. SCIPPR combines high-throughput single-cell proteomics with high-resolution flow cytometry, allowing researchers to analyze hundreds to thousands of cells in a short period of time.
The SCIPPR platform consists of several components, including innovative reagents, microfluidic cartridges, and advanced bioinformatics analysis. The reagents are designed to ensure high sensitivity and specificity for protein detection, while the microfluidic cartridges enable the isolation and profiling of individual cells in a controlled and reproducible manner. The bioinformatics analysis software provides powerful tools for data visualization, statistical analysis, and interpretation of the complex single-cell data generated.
Isoplexis Corporation's technology has a wide range of applications in biomedical research, including cancer immunotherapy, infectious diseases, autoimmune disorders, and drug discovery. By profiling the immune system at the single-cell level, researchers can gain insights into the heterogeneity and dynamic changes of immune cell populations, which can lead to the development of more effective therapies and personalized medicine approaches.
In addition to the SCIPPR platform, Isoplexis Corporation offers other products and services to support single-cell biology research. This includes CellPlex, a multiplexed imaging system that allows for the visualization and quantification of multiple biomarkers in intact tissues or cell cultures. They also provide custom assay development services, where they work closely with researchers to design and optimize assays for their specific needs.
Isoplexis Corporation has established collaborations with leading academic institutions, pharmaceutical companies, and research organizations around the world. These collaborations have resulted in numerous scientific publications and presentations, showcasing the impact and potential of the company's technology. The company is committed to advancing the field of single-cell biology and driving innovations that will ultimately improve human health.
Overall, Isoplexis Corporation is a pioneering biotechnology company that has revolutionized the field of single-cell biology with its SCIPPR platform. Their technology and products enable researchers to gain a deeper understanding of cellular heterogeneity and immune response, leading to the development of more targeted and personalized therapies. With a strong focus on innovation and collaboration, Isoplexis Corporation continues to push the boundaries of single-cell biology research.
Isoplexis Corporation is a biotechnology company specializing in advanced immune profiling and single-cell analysis. Their innovative technologies enable researchers and clinicians to gain deeper insights into the immune system, which is crucial for developing personalized therapies, especially in oncology and other immune-related diseases.
Segments
1. Research and Development:
- Isoplexis serves a wide array of research institutions and laboratories focusing on immunology, cancer research, and personalized medicine. This segment is geared towards academic institutions, pharmaceutical companies, and biotech firms engaged in cutting-edge research seeking to understand immune responses at a granular level.
2. Clinical Applications:
- The company targets healthcare providers and clinical professionals involved in patient care and treatment decision-making. Their technologies support clinical trials and diagnostics, helping to translate research findings into actionable insights for improving patient outcomes.
3. Pharmaceutical Collaboration:
- Isoplexis collaborates with pharmaceutical companies to aid in biomarker discovery, patient stratification, and therapeutic monitoring. This segment emphasizes partnerships that enhance drug development processes and personalized treatment options.
Products
1. IsoLight:
- This platform is known for its ability to measure cytokine and other immune signatures at the single-cell level. IsoLight provides a unique combination of high sensitivity, high throughput, and detailed immune profiling, allowing researchers to analyze millions of live cells in real time.
2. IsoSpeak:
- A software product that complements the IsoLight platform, IsoSpeak enables users to visualize and interpret the complex data generated from immune profiling. It provides users with comprehensive analytics and insights, facilitating the understanding of immune responses in various contexts.
3. Cellular Immune Profiling Services:
- Isoplexis offers services that utilize their technology for immune profiling, including customized assays tailored to specific research needs. These services help clients gain insights into cellular responses and immune activation patterns, crucial for developing targeted therapies.
4. Research Kits:
- The company provides various research kits designed to facilitate immune profiling in both pre-clinical and clinical research settings. These kits include reagents, consumables, and protocols to assist researchers in conducting their studies efficiently and effectively.
5. Consultative Services:
- Isoplexis provides expert consultancy in immune profiling and assay development, helping clients design experiments, interpret results, and apply findings to their specific research questions or therapeutic objectives.
Services
1. Technical Support and Training:
- To ensure optimal use of their platforms and products, Isoplexis offers comprehensive training sessions and ongoing technical support. This service is critical for clients who may need guidance in handling complex data or utilizing their systems efficiently.
2. Custom Assay Development:
- Isoplexis assists clients in developing custom assays that can be used for specific research or clinical applications. This tailored approach ensures that clients can meet their unique research objectives with precision and accuracy.
3. Data Analysis Services:
- The company provides expert data analysis services, helping clients interpret complex immune profiling data. This service adds value by extracting meaningful insights that can inform research directions and therapeutic strategies.
4. Collaboration Opportunities:
- Isoplexis encourages partnerships and collaborations with academic and pharmaceutical researchers, facilitating joint studies that leverage their advanced immune profiling technologies for development and validation of innovative therapies.
In essence, Isoplexis Corporation stands at the forefront of immune profiling technology, offering a range of products and services designed to empower researchers and healthcare providers in their quest to understand and manipulate the immune system for better health outcomes. Their commitment to innovation and collaboration underscores their role as a key player in the field of personalized medicine and immune research.
Segments
1. Research and Development:
- Isoplexis serves a wide array of research institutions and laboratories focusing on immunology, cancer research, and personalized medicine. This segment is geared towards academic institutions, pharmaceutical companies, and biotech firms engaged in cutting-edge research seeking to understand immune responses at a granular level.
2. Clinical Applications:
- The company targets healthcare providers and clinical professionals involved in patient care and treatment decision-making. Their technologies support clinical trials and diagnostics, helping to translate research findings into actionable insights for improving patient outcomes.
3. Pharmaceutical Collaboration:
- Isoplexis collaborates with pharmaceutical companies to aid in biomarker discovery, patient stratification, and therapeutic monitoring. This segment emphasizes partnerships that enhance drug development processes and personalized treatment options.
Products
1. IsoLight:
- This platform is known for its ability to measure cytokine and other immune signatures at the single-cell level. IsoLight provides a unique combination of high sensitivity, high throughput, and detailed immune profiling, allowing researchers to analyze millions of live cells in real time.
2. IsoSpeak:
- A software product that complements the IsoLight platform, IsoSpeak enables users to visualize and interpret the complex data generated from immune profiling. It provides users with comprehensive analytics and insights, facilitating the understanding of immune responses in various contexts.
3. Cellular Immune Profiling Services:
- Isoplexis offers services that utilize their technology for immune profiling, including customized assays tailored to specific research needs. These services help clients gain insights into cellular responses and immune activation patterns, crucial for developing targeted therapies.
4. Research Kits:
- The company provides various research kits designed to facilitate immune profiling in both pre-clinical and clinical research settings. These kits include reagents, consumables, and protocols to assist researchers in conducting their studies efficiently and effectively.
5. Consultative Services:
- Isoplexis provides expert consultancy in immune profiling and assay development, helping clients design experiments, interpret results, and apply findings to their specific research questions or therapeutic objectives.
Services
1. Technical Support and Training:
- To ensure optimal use of their platforms and products, Isoplexis offers comprehensive training sessions and ongoing technical support. This service is critical for clients who may need guidance in handling complex data or utilizing their systems efficiently.
2. Custom Assay Development:
- Isoplexis assists clients in developing custom assays that can be used for specific research or clinical applications. This tailored approach ensures that clients can meet their unique research objectives with precision and accuracy.
3. Data Analysis Services:
- The company provides expert data analysis services, helping clients interpret complex immune profiling data. This service adds value by extracting meaningful insights that can inform research directions and therapeutic strategies.
4. Collaboration Opportunities:
- Isoplexis encourages partnerships and collaborations with academic and pharmaceutical researchers, facilitating joint studies that leverage their advanced immune profiling technologies for development and validation of innovative therapies.
In essence, Isoplexis Corporation stands at the forefront of immune profiling technology, offering a range of products and services designed to empower researchers and healthcare providers in their quest to understand and manipulate the immune system for better health outcomes. Their commitment to innovation and collaboration underscores their role as a key player in the field of personalized medicine and immune research.